Transient Efficacy of Double High-Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation, Immunoglobulin, Thalidomide, and Bortezomib in the Treatment of Scleromyxedema

Author: Ataergin Selmin  

Publisher: Adis International

ISSN: 1175-0561

Source: American Journal of Clinical Dermatology, Vol.9, Iss.4, 2008-01, pp. : 271-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content